 HomeProductsKey IntermediatesCAS 302962-49-8 Dasatinib for Anti-Cancer

Contact Supplier

Ms. Caroline

Leave a message

Contact Now

You May Like

Antiviral intermediates Atazanavir intermediate 98737-29-2 Contact Now

Antiviral intermediates Atazanavir intermediate 198904-86-8 Contact Now

Antiviral intermediates Atazanavir intermediate 198904-85-7 Contact Now

Antiviral intermediates Atazanavir intermediate 98760-08-8 Contact Now

Antiviral drug intermediates Methoxycarbonyl-L-tert-leucine Contact Now

carbapenem antibiotics Penem intermediate CAS 76855-69-1 Contact Now

carbapenem antibiotics Imipenem intermediate CAS 74288-40-7 Contact Now

carbapenem antibiotics Meropenem intermediate CAS 90776-58-2 Contact Now

 

CAS 302962-49-8 Dasatinib for Anti-Cancer

Name: Nefiracetam
Uploaded: 2022-12-18T16:30:47+08:00
Description: Dasatinib, also formerly BMS-354825, is a cancer treatment drug marketed by Bristol-Myers Squibb and marketed under

$20 - 50 /Gram

100 /Gram (Min. Order)

option:

Dasatinib

Payment Type:

T/T

Incoterm:

FOB,CIF,Express Delivery

Min. Order:

100 Gram

Transportation:

Ocean,Land,Air,Express

Port:

Shenzhen,Shanghai,Hongkong

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: Dasatinib

Brand: Rhine

Shelf Life: 2years

CAS: 302962-49-8

Test Method: HPLC

Packaging: Foil Bag Drum

Grade Standard: Medical Grade

Characteristic: white powder

Assay: 99%

MF: C22h26cln7o2s

MW: 488.01

Product Name: Dasatinib

Supply Ability & Additional Information

Packaging: Foil Bag Drum

Productivity: 50kg/month

Transportation: Ocean,Land,Air,Express

Place of Origin: china

Supply Ability: 50kg/month

Certificate: N/A

HS Code: /

Port: Shenzhen,Shanghai,Hongkong

Payment Type: T/T

Incoterm: FOB,CIF,Express Delivery

Packaging & Delivery

Selling Units:: Gram

Package Type:: Foil Bag Drum

Dasatinib, also formerly BMS-354825, is a cancer treatment drug marketed by Bristol-Myers Squibb and marketed under the name"Sprycel." Dasatinib is a tyrosine kinase inhibitor against the Philadelphia chromosome and Src gene variants and is mainly used in the treatment of chronic myeloid leukemia (imatinib) chronic myelogenous leukemia, and Philadelphia chromosome positive acute myeloid leukemia (Ph + ALL) patients. The drug has also been shown to treat many other types of cancer, including...

Product Categories : Key Intermediates

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Caroline
*Email:
*Message:

Your message must be between 20-8000 characters